Mesotrypsin expression has been observed in a number of different cancers including non-small cell lung cancer (NSCLC) [15], breast [16], esophageal [17], pancreatic [18], prostate [19], and ovarian cancers [20]. Here, PRSS3 is linked to ovarian carcinoma.